Pharmagen, Inc. (PHRX)

Pharmagen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Mar 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Cash & Equivalents	0.26	0.23	0.32	0.04	0.01
Cash & Short-Term Investments	0.26	0.23	0.32	0.04	0.01
Cash Growth	-59.09%	-29.94%	734.38%	467.50%	-
Receivables	0.33	0.37	0.64	0.21	0.05
Inventory	0.17	0.14	0.15	0.01	0.06
Prepaid Expenses	0.08	0.06	0.28	0.01	-
Other Current Assets	-	0.09	0.2	-	-
Total Current Assets	0.84	0.88	1.59	0.27	0.11
Property, Plant & Equipment	0.42	0.38	0.09	0.03	-
Goodwill	-	-	1.2	-	-
Other Intangible Assets	0.02	0.02	0.02	-	-
Total Assets	1.28	1.28	2.9	0.3	0.11
Accounts Payable	1.73	1.38	0.78	0.2	0.05
Short-Term Debt	0.52	1.66	1.29	0.48	0.13
Current Portion of Long-Term Debt	2.04	2.16	0.25	-	-
Current Portion of Leases	0.04	0.04	-	-	-
Other Current Liabilities	3.97	2.86	0.11	-	-
Total Current Liabilities	8.29	8.1	2.43	0.67	0.19
Long-Term Debt	0.52	0.5	1.25	-	-
Long-Term Leases	0.27	0.27	-	-	-
Other Long-Term Liabilities	-	-	1.9	-	-
Total Liabilities	9.08	8.87	5.59	0.67	0.19
Common Stock	0.51	0.43	0.38	0.2	0
Additional Paid-In Capital	1.32	1.48	0.17	-	-
Retained Earnings	-9.86	-9.15	-3.15	-0.38	-0.08
Comprehensive Income & Other	-	-0.48	-0.09	-0.2	-
Total Common Equity	-8.03	-7.72	-2.69	-0.37	-0.08
Shareholders' Equity	-7.8	-7.59	-2.69	-0.37	-0.08
Total Liabilities & Equity	1.28	1.28	2.9	0.3	0.11
Total Debt	3.39	4.63	2.79	0.48	0.13
Net Cash (Debt)	-3.13	-4.4	-2.47	-0.44	-0.13
Net Cash Per Share	-0.01	-0.01	-0.01	-0.00	-
Filing Date Shares Outstanding	517.08	498.58	381.13	200	-
Total Common Shares Outstanding	504.45	434.41	381.13	200	-
Working Capital	-7.46	-7.22	-0.85	-0.4	-0.08
Book Value Per Share	-0.02	-0.02	-0.01	-0.00	-
Tangible Book Value	-8.05	-7.74	-3.92	-0.37	-0.08
Tangible Book Value Per Share	-0.02	-0.02	-0.01	-0.00	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.